Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Relmada Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RLMD.
You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.
Other companies in Relmada Therapeutics’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Addex Therapeutics (NASDAQ:ADXN) and Kiora Pharmaceuticals (NASDAQ:KPRX).
Relmada Therapeutics has a consensus price target of $8.83.
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $0.2501 last updated April 4, 2025 at 7:09 PM EDT.
There are no upcoming dividends for Relmada Therapeutics.
Relmada Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Relmada Therapeutics.
Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.